Company Overview of Psyadon Pharmaceuticals, Inc.
Psyadon Pharmaceuticals, Inc. engages in the discovery and development of drugs for the treatment of diseases afflicting the central nervous system, primarily neurological and psychiatric diseases. Its Ecopipam product is an antagonist of the D1 dopamine receptor that blocks the actions of the neurotransmitter dopamine at the D1 receptor-family in the brain. Psyadon Pharmaceuticals, Inc. was formerly known as Ruxton Pharmaceuticals, Inc. and changed its name in November 2008. The company was founded in 2004 and is based in Germantown, Maryland.
20451 Seneca Meadows Parkway
Germantown, MD 20876
Founded in 2004
Key Executives for Psyadon Pharmaceuticals, Inc.
Psyadon Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Protea Biosciences Group, Inc||United States|
|CytoSolv Inc.||United States|
|Synomics Pharmaceutical Services LLC||United States|
|Alacritas Biopharma, Inc.||United States|
|Cardinal Health 100, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Ohio | Boehringer IngelheimPosted: May 05
- Louisville, KY | AstraZenecaPosted: May 21
- Field, KY | Shire PharmaceuticalsPosted: May 18
Sponsored Financial Commentaries
To contact Psyadon Pharmaceuticals, Inc., please visit www.psyadonrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.